Research Point Global and WuXi Clinical Development Services have revealed that they are to combine and rebrand as a new CRO, WuXi Clinical.
Research Point Global and WuXi Clinical Development Services (CDS) have revealed that they are to combine and rebrand as a new contract research organization (CRO), WuXi Clinical.
The rebranded CRO will be launched during DIA 2019, which will be held June 23–27, 2019 in San Diego, CA, and is set to specialize in collaborative partnering for global clinical trials. The combined offering will focus on enlarging opportunities across small to mid-tier clients and will feature expanded capabilities to provide further benefits to clients as a gateway partner into the clinical trial space in China.
“Our goal as WuXi Clinical is to continue to work with our client partners to be greater than the sum of our parts,” commented Becky Carpenter, head of North America/Euro Operations at WuXi Clinical. “In fact, our new company strategy is entirely focused around how we can work ‘better together’.”
“This is a hugely exciting time for WuXi Clinical as we bring together our focus on providing a very collaborative customer approach, coupled with additional resources. Our targets for this year are to cement our offering amongst mid-tier pharma, and we anticipate good traction in the market,” added Johnathan Lee, general manager and head of WuXi Clinical. “With our combined capabilities, we now have a crucial role to play in maximizing new opportunities and working as a bridge between R&D markets in the US and China.”
Source: WuXi Clinical
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.